Equitable treatment for HIV/AIDS clinical trial participants: a focus group study of patients, clinician researchers, and administrators in western Kenya
Share this article
Click the icon of the social media platform on which you would like to share this article.
Email this article to a friend
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers
- Cancer clinical research in Latin America: current situation and opportunities. Expert opinion from the first ESMO workshop on clinical trials, Lima, 2015
- Supporting positive experiences and sustained participation in clinical trials: looking beyond information provision
- Cross-sectional assessment of patient attitudes towards participation in clinical trials: does making results publicly available matter?
- Conducting an ongoing HIV clinical trial during the COVID-19 pandemic in Uganda: a qualitative study of research team and participants’ experiences and lessons learnt
- Acceptability of donor funding for clinical trials in the UK: a qualitative empirical ethics study using focus groups to elicit the views of research patient public involvement group members, research ethics committee chairs and clinical researchers
- Engaging African ancestry participants in SLE clinical trials
- Barriers to uptake and use of pre-exposure prophylaxis (PrEP) among communities most affected by HIV in the UK: findings from a qualitative study in Scotland
- Oncology patients’ experiences in experimental medicine cancer trials: a qualitative study
- Perspectives of people with inherited retinal diseases on ocular gene therapy in Australia: protocol for a national survey